John C Alverdy

23PUBLICATIONS
32CO-AUTHORS
Food properties (incl. characteristics and health benefits)Molecular targetsMedical infection agents (incl. prions)Satisfiability and optimisationInfectious diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Feb 09, 2026
IL-6R blockade with tocilizumab disrupts pericyte- and tumor cell-driven IL-6/STAT3 signaling, enhancing docetaxel efficacy in ER+ breast cancer.

Róża Przanowska, Jacky Gomez-Villa, Victoria J Liu

|Jul 17, 2025
The Scientific Rationale for Diversity, Equity, and Inclusion: Nature-inspired Design.

John C Alverdy, Selwyn O Rogers

|Mar 06, 2025
Unpacking the sepsis controversy.

John Alverdy

|Jan 08, 2025
Enterobactin inhibits microbiota-dependent activation of AhR to promote bacterial sepsis in mice.

Robert C Keskey, Jason Xiao, Sanjiv Hyoju

Pageof 4